Literature DB >> 24938021

Mammaglobin A: review and clinical utility.

Sergio Ghersevich, María Paula Ceballos.   

Abstract

Mammaglobin A is a protein that belongs to the secretoglobin superfamily. It has highly specific expression in cells from most breast cancers and may be used to detect circulating or disseminated tumor cells. In addition, mammaglobin A is currently under inves tigation as a potential therapeutic target for immune therapies that target breast cancer. The present review will highlight our current understanding of mammaglobin A at the genetic and protein level and its potential clinical applications. Characteristics of breast cancer and methods used to isolate and detect circulating tumor cells will also be presented.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24938021

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN： 0065-2423            Impact factor:   5.394


  6 in total

Review 1.  Review: circulating tumor cells in the practice of breast cancer oncology.

Authors:  R Ramos-Medina; F Moreno; S Lopez-Tarruella; M Del Monte-Millán; I Márquez-Rodas; E Durán; Y Jerez; J A Garcia-Saenz; I Ocaña; S Andrés; T Massarrah; M González-Rivera; M Martin
Journal:  Clin Transl Oncol       Date:  2015-12-08       Impact factor: 3.405

Review 2.  The role and function of CLU in cancer biology and therapy.

Authors:  Yefei Zhang; Xiang Lv; Liming Chen; Yan Liu
Journal:  Clin Exp Med       Date:  2022-09-13       Impact factor: 5.057

3.  Generation of monoclonal antibodies against MGA and comparison of their application in breast cancer detection by immunohistochemistry.

Authors:  Cuimi Duan; Xiqin Yang; Xuhui Zhang; Jiannan Feng; Zhiqiang Liu; Haiping Que; Heather Johnson; Yanfeng Zhao; Yawen Fan; Yinglin Lu; Heqiu Zhang; Yan Huang; Bingshui Xiu; Xiaoyan Feng
Journal:  Sci Rep       Date:  2015-08-14       Impact factor: 4.379

4.  Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) Spectroscopy Analysis of Saliva for Breast Cancer Diagnosis.

Authors:  Izabella C C Ferreira; Emília M G Aguiar; Alinne T F Silva; Letícia L D Santos; Léia Cardoso-Sousa; Thaise G Araújo; Donizeti W Santos; Luiz R Goulart; Robinson Sabino-Silva; Yara C P Maia
Journal:  J Oncol       Date:  2020-02-10       Impact factor: 4.375

5.  Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination.

Authors:  Nadia Nocera Zachariah; Amrita Basu; Namrata Gautam; Ganesan Ramamoorthi; Krithika N Kodumudi; Nagi B Kumar; Loretta Loftus; Brian J Czerniecki
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

6.  Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.

Authors:  Siddhartha P Kar; Daniel P C Considine; Jonathan P Tyrer; Jasmine T Plummer; Stephanie Chen; Felipe S Dezem; Alvaro N Barbeira; Padma S Rajagopal; Will T Rosenow; Fernando Moreno; Clara Bodelon; Jenny Chang-Claude; Georgia Chenevix-Trench; Anna deFazio; Thilo Dörk; Arif B Ekici; Ailith Ewing; George Fountzilas; Ellen L Goode; Mikael Hartman; Florian Heitz; Peter Hillemanns; Estrid Høgdall; Claus K Høgdall; Tomasz Huzarski; Allan Jensen; Beth Y Karlan; Elza Khusnutdinova; Lambertus A Kiemeney; Susanne K Kjaer; Rüdiger Klapdor; Martin Köbel; Jingmei Li; Clemens Liebrich; Taymaa May; Håkan Olsson; Jennifer B Permuth; Paolo Peterlongo; Paolo Radice; Susan J Ramus; Marjorie J Riggan; Harvey A Risch; Emmanouil Saloustros; Jacques Simard; Lukasz M Szafron; Linda Titus; Cheryl L Thompson; Robert A Vierkant; Stacey J Winham; Wei Zheng; Jennifer A Doherty; Andrew Berchuck; Kate Lawrenson; Hae Kyung Im; Ani W Manichaikul; Paul D P Pharoah; Simon A Gayther; Joellen M Schildkraut
Journal:  HGG Adv       Date:  2021-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.